Vol 5, No 3 (2016)

Date published: 2016-09-07

Table of Contents

open access

The voice of the editor-in-chief


Clinical Diabetology 2016;5(3).
Original articles (submitted)

Optical coherence tomography angiography — novel method to access retinal microcirculation in patients with diabetic retinopathy

Małgorzata Loba, Maria Jędrzejak, Monika Spychała, Jerzy Loba

Research paper

DOI: 10.5603/DK.2016.0013
Clinical Diabetology 2016;5(3):77-82.

Efficacy and safety of Glycebal (PDM011011) capsules as adjuvant therapy in subjects with type 2 diabetes mellitus: an open label, randomized, active controlled, phase II trial

Ashish C. Suthar, Anand Deshmukh, Vijaya Babu, Vijaya S. Mohan, Madhukar V. Chavan, Dutta Kumar, Vijaysingh Chauhan, Somesh Sharma, Mahesh Sharma

Research paper

DOI: 10.5603/DK.2016.0015
Clinical Diabetology 2016;5(3):88-94.

Active screening for diabetic foot — assessment of health care professionals’ compliance to it

Edyta Ewa Sutkowska, Michał Sokołowski, Krystyna Zdrojowy, Szymon Dragan

Research paper

DOI: 10.5603/DK.2016.0014
Clinical Diabetology 2016;5(3):83-87.
Review articles (submitted)

Dysfunction of the lower gastrointestinal tract as a complication of diabetes — a problematic issue in the diabetic care

Małgorzata Reszczyńska, Beata Marczak-Karpina

Review paper

DOI: 10.5603/DK.2016.0017
Clinical Diabetology 2016;5(3):95-99.

miRNA in type 2 diabetes

Nikola Szweda, Łukasz Łaczmański

Review paper

DOI: 10.5603/DK.2016.0016
Clinical Diabetology 2016;5(3):100-106.
Pharmaceutical news

Empagliflozin. Results of the EMPA-REG OUTCOME trial. A breakthrough in treatment of type 2 diabetes?

Krzysztof Strojek, Dominika Rokicka, Aleksandra Szymborska-Kajanek, Marta Wróbel

Other materials agreed with the Editors

DOI: 10.5603/DK.2016.0018
Clinical Diabetology 2016;5(3):107-110.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.


Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl